SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-023627
Filing Date
2023-05-23
Accepted
2023-05-23 16:06:20
Documents
12
Period of Report
2023-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K vir-20230519.htm   iXBRL 8-K 109661
  Complete submission text file 0000950170-23-023627.txt   225343

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20230519_pre.xml EX-101.PRE 10552
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20230519_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20230519.xsd EX-101.SCH 2456
6 EXTRACTED XBRL INSTANCE DOCUMENT vir-20230519_htm.xml XML 4530
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 23948967
SIC: 2836 Biological Products, (No Diagnostic Substances)